Profund Advisors LLC Recursion Pharmaceuticals, Inc. Transaction History
Profund Advisors LLC
- $2.59 Billion
- Q3 2024
A detailed history of Profund Advisors LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 132,811 shares of RXRX stock, worth $961,551. This represents 0.03% of its overall portfolio holdings.
Number of Shares
132,811
Previous 74,771
77.62%
Holding current value
$961,551
Previous $560,000
56.25%
% of portfolio
0.03%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding RXRX
# of Institutions
299Shares Held
241MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$237 Million2.05% of portfolio
-
Baillie Gifford & CO24.9MShares$180 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$125 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$111 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.31B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...